Consistent with this is the observation that BRCA1/2-initiated breast cancers have very high rates (29–84%) of somatic p53 mutations compared to 14–35% in non-BRCA1/2-related breast cancer [6]. The gene discussed is BRCA1; the disease is breast carcinoma.